{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:36:57Z","timestamp":1789133817592,"version":"build-2803163510"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,31]]},"DOI":"10.7759\/cureus.42772","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T04:47:34Z","timestamp":1690865254000},"source":"Crossref","is-referenced-by-count":5,"title":["Choices and Challenges With Treatment of Myasthenia Gravis in Pregnancy: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Lakshya","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meet Popatbhai","family":"Kachhadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jashanpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khutaija","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rushi G","family":"Gohel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paramjeet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Raiyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vatsal A","family":"Gohel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Advait M","family":"Vasavada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2017.1241144","article-title":"Myasthenia gravis: recent advances in immunopathology and therapy","volume":"17","author":"Lee JI","year":"2017","unstructured":"Lee JI, Jander S. Myasthenia gravis: recent advances in immunopathology and therapy. Expert Rev Neurother. 2017, 17:287-99. 10.1080\/14737175.2017.1241144","journal-title":"Expert Rev Neurother"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/847393","article-title":"Myasthenia gravis: a review of available treatment approaches","volume":"2011","author":"Gilhus NE","year":"2011","unstructured":"Gilhus NE, Owe JF, Hoff JM, Romi F, Skeie GO, Aarli JA. Myasthenia gravis: a review of available treatment approaches. Autoimmune Dis. 2011, 2011:847393. 10.4061\/2011\/847393","journal-title":"Autoimmune Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus NE","year":"2016","unstructured":"Gilhus NE. Myasthenia gravis. N Engl J Med. 2016, 375:2570-81. 10.1056\/NEJMra1602678","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1017","article-title":"Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis","volume":"50","author":"Buckley C","year":"2001","unstructured":"Buckley C, Douek D, Newsom-Davis J, Vincent A, Willcox N. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Ann Neurol. 2001, 50:64-72. 10.1002\/ana.1017","journal-title":"Ann Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2005.01.002","article-title":"Myasthenia gravis: management issues during pregnancy","volume":"121","author":"Ferrero S","year":"2005","unstructured":"Ferrero S, Pretta S, Nicoletti A, Petrera P, Ragni N. Myasthenia gravis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2005, 121:129-38. 10.1016\/j.ejogrb.2005.01.002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-020-01549-z","article-title":"Gender differences in quality of life among patients with myasthenia gravis in China","volume":"18","author":"Dong D","year":"2020","unstructured":"Dong D, Chong MK, Wu Y, et al.. Gender differences in quality of life among patients with myasthenia gravis in China. Health Qual Life Outcomes. 2020, 18:296. 10.1186\/s12955-020-01549-z","journal-title":"Health Qual Life Outcomes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"Grob D","year":"2008","unstructured":"Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve. 2008, 37:141-9. 10.1002\/mus.20950","journal-title":"Muscle Nerve"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12217","article-title":"Myasthenia gravis: an update for the clinician","volume":"175","author":"Sieb JP","year":"2014","unstructured":"Sieb JP. Myasthenia gravis: an update for the clinician. Clin Exp Immunol. 2014, 175:408-18. 10.1111\/cei.12217","journal-title":"Clin Exp Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27497","article-title":"Clinical course and outcome of an outpatient clinic population with myasthenia gravis and COVID-19","volume":"65","author":"Gungor Tuncer O","year":"2022","unstructured":"Gungor Tuncer O, Deymeer F. Clinical course and outcome of an outpatient clinic population with myasthenia gravis and COVID-19. Muscle Nerve. 2022, 65:447-52. 10.1002\/mus.27497","journal-title":"Muscle Nerve"},{"key":"ref10","article-title":"Myasthenia gravis during pregnancy","volume":"58","author":"Chaudhry SA","year":"2012","unstructured":"Chaudhry SA, Vignarajah B, Koren G. Myasthenia gravis during pregnancy. Can Fam Physician. 2012, 58:1346-9.","journal-title":"Can Fam Physician"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-005-0022-2","article-title":"An update on myasthenic crisis","volume":"7","author":"Ahmed S","year":"2005","unstructured":"Ahmed S, Kirmani JF, Janjua N, et al.. An update on myasthenic crisis. Curr Treat Options Neurol. 2005, 7:129-41. 10.1007\/s11940-005-0022-2","journal-title":"Curr Treat Options Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/1941875210382918","article-title":"Myasthenic crisis","volume":"1","author":"Wendell LC","year":"2011","unstructured":"Wendell LC, Levine JM. Myasthenic crisis. Neurohospitalist. 2011, 1:16-22. 10.1177\/1941875210382918","journal-title":"Neurohospitalist"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00604","article-title":"A practical approach to managing patients with myasthenia gravis-opinions and a review of the literature","volume":"11","author":"Farrugia ME","year":"2020","unstructured":"Farrugia ME, Goodfellow JA. A practical approach to managing patients with myasthenia gravis-opinions and a review of the literature. Front Neurol. 2020, 11:604. 10.3389\/fneur.2020.00604","journal-title":"Front Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.01.011","article-title":"Treatment of myasthenia gravis","volume":"36","author":"Farmakidis C","year":"2018","unstructured":"Farmakidis C, Pasnoor M, Dimachkie MM, Barohn RJ. Treatment of myasthenia gravis. Neurol Clin. 2018, 36:311-37. 10.1016\/j.ncl.2018.01.011","journal-title":"Neurol Clin"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8045-z","article-title":"Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society","volume":"263","author":"Melzer N","year":"2016","unstructured":"Melzer N, Ruck T, Fuhr P, et al.. Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society. J Neurol. 2016, 263:1473-94. 10.1007\/s00415-016-8045-z","journal-title":"J Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-829595","article-title":"Myasthenia gravis: management of myasthenic crisis and perioperative care","volume":"24","author":"Juel VC","year":"2004","unstructured":"Juel VC. Myasthenia gravis: management of myasthenic crisis and perioperative care. Semin Neurol. 2004, 24:75-81. 10.1055\/s-2004-829595","journal-title":"Semin Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-019-02029-0","article-title":"Myasthenia gravis and pregnancy: retrospective evaluation of 27 pregnancies in a tertiary center and comparison with previous studies","volume":"188","author":"Tanacan A","year":"2019","unstructured":"Tanacan A, Fadiloglu E, Ozten G, Gunes AC, Orgul G, Beksac MS. Myasthenia gravis and pregnancy: retrospective evaluation of 27 pregnancies in a tertiary center and comparison with previous studies. Ir J Med Sci. 2019, 188:1261-7. 10.1007\/s11845-019-02029-0","journal-title":"Ir J Med Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25095","article-title":"Myasthenia gravis in pregnancy: experience of a Portuguese center","volume":"54","author":"Braga AC","year":"2016","unstructured":"Braga AC, Pinto C, Santos E, Braga J. Myasthenia gravis in pregnancy: experience of a Portuguese center. Muscle Nerve. 2016, 54:715-20. 10.1002\/mus.25095","journal-title":"Muscle Nerve"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0301-2115(02)00051-9","article-title":"Myasthenia gravis in pregnancy: report on 69 cases","volume":"104","author":"Djelmis J","year":"2002","unstructured":"Djelmis J, Sostarko M, Mayer D, Ivanisevic M. Myasthenia gravis in pregnancy: report on 69 cases. Eur J Obstet Gynecol Reprod Biol. 2002, 104:21-5. 10.1016\/s0301-2115(02)00051-9","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.03.012","article-title":"Transient neonatal myasthenia gravis due to a mother with ocular onset of anti-muscle specific kinase myasthenia gravis","volume":"27","author":"Lee JY","year":"2017","unstructured":"Lee JY, Min JH, Han SH, Han J. Transient neonatal myasthenia gravis due to a mother with ocular onset of anti-muscle specific kinase myasthenia gravis. Neuromuscul Disord. 2017, 27:655-7. 10.1016\/j.nmd.2017.03.012","journal-title":"Neuromuscul Disord"},{"key":"ref21","article-title":"Neonatal myasthenia gravis","author":"Bardhan M","year":"2023","unstructured":"Bardhan M, Dogra H, Samanta D. Neonatal myasthenia gravis. StatPearls Publishing, Treasure Island, Florida; 2023."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.20592","article-title":"Transient neonatal myasthenia gravis: a case report","volume":"13","author":"Santiago Gon\u00e7alves C","year":"2021","unstructured":"Santiago Gon\u00e7alves C, Nunes Marques MI, Antunes S, Serrano A. Transient neonatal myasthenia gravis: a case report. Cureus. 2021, 13:e20592. 10.7759\/cureus.20592","journal-title":"Cureus"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.83356","article-title":"Maternal and neonatal outcome of pregnancies with autoimmune myasthenia gravis","author":"Jovandaric MZ","year":"2019","unstructured":"Jovandaric MZ, Milenkovic SJ, Jovandaric MZ, Milenkovic SJ. Maternal and neonatal outcome of pregnancies with autoimmune myasthenia gravis. IntechOpen. 2019, 10.5772\/intechopen.83356","journal-title":"IntechOpen"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021, 10:89. 10.1186\/s13643-021-01626-4","journal-title":"Syst Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2020-209567","article-title":"Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews","volume":"37","author":"Amir-Behghadami M","year":"2020","unstructured":"Amir-Behghadami M, Janati A. Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews. Emerg Med J. 2020, 37:387. 10.1136\/emermed-2020-209567","journal-title":"Emerg Med J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.11124\/JBISRIR-D-19-00099","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn Z","year":"2020","unstructured":"Munn Z, Barker TH, Moola S, et al.. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020, 18:2127-33. 10.11124\/JBISRIR-D-19-00099","journal-title":"JBI Evid Synth"},{"key":"ref27","article-title":"The Joanna Briggs Institute Critical Appraisal tools for use in JBI systematic reviews: checklist for case series","year":"2019","unstructured":"The Joanna Briggs Institute Critical Appraisal tools for use in JBI systematic reviews. checklist for case series. Joanna Briggs Institute, Adelaide, Australia; 2019."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0b013e32833e263f","article-title":"Myasthenia gravis and pregnancy: anaesthetic management--a series of cases","volume":"27","author":"Almeida C","year":"2010","unstructured":"Almeida C, Coutinho E, Moreira D, Santos E, Aguiar J. Myasthenia gravis and pregnancy: anaesthetic management--a series of cases. Eur J Anaesthesiol. 2010, 27:985-90. 10.1097\/EJA.0b013e32833e263f","journal-title":"Eur J Anaesthesiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13641","article-title":"Risk factors associated with adverse pregnancy outcomes and postpartum exacerbation in women with myasthenia gravis","volume":"88","author":"Zhou Q","year":"2022","unstructured":"Zhou Q, Yin W, Zhu J, Duan W, Li Y, Jin W, Yang H. Risk factors associated with adverse pregnancy outcomes and postpartum exacerbation in women with myasthenia gravis. Am J Reprod Immunol. 2022, 88:e13641. 10.1111\/aji.13641","journal-title":"Am J Reprod Immunol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.01.021","article-title":"Clinical follow-up of pregnancy in myasthenia gravis patients","volume":"27","author":"Ducci RD","year":"2017","unstructured":"Ducci RD, Lorenzoni PJ, Kay CS, Werneck LC, Scola RH. Clinical follow-up of pregnancy in myasthenia gravis patients. Neuromuscul Disord. 2017, 27:352-7. 10.1016\/j.nmd.2017.01.021","journal-title":"Neuromuscul Disord"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.10.037","article-title":"Intravenous immunoglobulin as monotherapy for myasthenia gravis during pregnancy","volume":"383","author":"Gamez J","year":"2017","unstructured":"Gamez J, Salvado M, Casellas M, Manrique S, Castillo F. Intravenous immunoglobulin as monotherapy for myasthenia gravis during pregnancy. J Neurol Sci. 2017, 383:118-22. 10.1016\/j.jns.2017.10.037","journal-title":"J Neurol Sci"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.11.014","article-title":"MuSK myasthenia gravis and pregnancy","volume":"28","author":"Santos E","year":"2018","unstructured":"Santos E, Braga A, Gabriel D, et al.. MuSK myasthenia gravis and pregnancy. Neuromuscul Disord. 2018, 28:150-3. 10.1016\/j.nmd.2017.11.014","journal-title":"Neuromuscul Disord"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1515\/biol-2018-0004","article-title":"Management of myasthenia gravis during pregnancy: a report of eight cases","volume":"13","author":"Shi B","year":"2018","unstructured":"Shi B, Zeng L. Management of myasthenia gravis during pregnancy: a report of eight cases. Open Life Sci. 2018, 13:28-33. 10.1515\/biol-2018-0004","journal-title":"Open Life Sci"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-5-42","article-title":"Myasthenia gravis and pregnancy: clinical implications and neonatal outcome","volume":"5","author":"T\u00e9llez-Zenteno JF","year":"2004","unstructured":"T\u00e9llez-Zenteno JF, Hern\u00e1ndez-Ronquillo L, Salinas V, Estanol B, da Silva O. Myasthenia gravis and pregnancy: clinical implications and neonatal outcome. BMC Musculoskelet Disord. 2004, 5:42. 10.1186\/1471-2474-5-42","journal-title":"BMC Musculoskelet Disord"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/jog.13922","article-title":"Management of labor and delivery in myasthenia gravis: a new protocol","volume":"45","author":"Tsurane K","year":"2019","unstructured":"Tsurane K, Tanabe S, Miyasaka N, Matsuda M, Takahara M, Ida T, Kohyama A. Management of labor and delivery in myasthenia gravis: a new protocol. J Obstet Gynaecol Res. 2019, 45:974-80. 10.1111\/jog.13922","journal-title":"J Obstet Gynaecol Res"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2021.2","article-title":"Myasthenia gravis and pregnancy: Toronto specialty center experience","volume":"48","author":"Alharbi M","year":"2021","unstructured":"Alharbi M, Menon D, Barnett C, Katzberg H, Sermer M, Bril V. Myasthenia gravis and pregnancy: Toronto specialty center experience. Can J Neurol Sci. 2021, 48:767-71. 10.1017\/cjn.2021.2","journal-title":"Can J Neurol Sci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003339","article-title":"Increased risk for clinical onset of myasthenia gravis during the postpartum period","volume":"87","author":"Boldingh MI","year":"2016","unstructured":"Boldingh MI, Maniaol AH, Brunborg C, Weedon-Fekj\u00e6r H, Verschuuren JJ, Tallaksen CM. Increased risk for clinical onset of myasthenia gravis during the postpartum period. Neurology. 2016, 87:2139-45. 10.1212\/WNL.0000000000003339","journal-title":"Neurology"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02205-z","article-title":"Risk factors for pregnancy-related clinical outcome in myasthenia gravis: a systemic review and meta-analysis","volume":"17","author":"Su M","year":"2022","unstructured":"Su M, Liu X, Wang L, Song J, Zhou Z, Luo S, Zhao C. Risk factors for pregnancy-related clinical outcome in myasthenia gravis: a systemic review and meta-analysis. Orphanet J Rare Dis. 2022, 17:52. 10.1186\/s13023-022-02205-z","journal-title":"Orphanet J Rare Dis"},{"key":"ref39","article-title":"Management of pregnancy with myasthenia gravis: 7 cases report (Article in Chinese)","volume":"47","author":"Qi QW","year":"2012","unstructured":"Qi QW, Wang D, Liu JT, Bian XM. Management of pregnancy with myasthenia gravis: 7 cases report (Article in Chinese). Zhonghua Fu Chan Ke Za Zhi. 2012, 47:241-4.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000082725.21444.ec","article-title":"Myasthenia gravis: consequences for pregnancy, delivery, and the newborn","volume":"61","author":"Hoff JM","year":"2003","unstructured":"Hoff JM, Daltveit AK, Gilhus NE. Myasthenia gravis: consequences for pregnancy, delivery, and the newborn. Neurology. 2003, 61:1362-6. 10.1212\/01.wnl.0000082725.21444.ec","journal-title":"Neurology"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01538.x","article-title":"Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care","volume":"14","author":"Hoff JM","year":"2007","unstructured":"Hoff JM, Daltveit AK, Gilhus NE. Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. Eur J Neurol. 2007, 14:38-43. 10.1111\/j.1468-1331.2006.01538.x","journal-title":"Eur J Neurol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02689.x","article-title":"No increased risk of adverse pregnancy outcomes for women with myasthenia gravis: a nationwide population-based study","volume":"16","author":"Wen JC","year":"2009","unstructured":"Wen JC, Liu TC, Chen YH, Chen SF, Lin HC, Tsai WC. No increased risk of adverse pregnancy outcomes for women with myasthenia gravis: a nationwide population-based study. Eur J Neurol. 2009, 16:889-94. 10.1111\/j.1468-1331.2009.02689.x","journal-title":"Eur J Neurol"},{"key":"ref43","article-title":"Outcome of myasthenia gravis mothers and their infants","volume":"48","author":"Cheng I","year":"2007","unstructured":"Cheng I, Lin CH, Lin MI, Lee JS, Chiu HC, Mu SC. Outcome of myasthenia gravis mothers and their infants. Acta Paediatr Taiwan. 2007, 48:141-5.","journal-title":"Acta Paediatr Taiwan"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1055\/a-1541-7964","article-title":"Recommendations of the AGG (section maternal disease) for myasthenia gravis in pregnancy","volume":"81","author":"K\u00fchnert M","year":"2021","unstructured":"K\u00fchnert M, Schmidt M, Kuschel B, Sch\u00e4fer-Graf UM. Recommendations of the AGG (section maternal disease) for myasthenia gravis in pregnancy. Geburtshilfe Frauenheilkd. 2021, 81:1301-6. 10.1055\/a-1541-7964","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2023.2178302","article-title":"Treatment considerations in myasthenia gravis for the pregnant patient","volume":"23","author":"Gilhus NE","year":"2023","unstructured":"Gilhus NE. Treatment considerations in myasthenia gravis for the pregnant patient. Expert Rev Neurother. 2023, 23:169-77. 10.1080\/14737175.2023.2178302","journal-title":"Expert Rev Neurother"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00554","article-title":"Myasthenia gravis can have consequences for pregnancy and the developing child","volume":"11","author":"Gilhus NE","year":"2020","unstructured":"Gilhus NE. Myasthenia gravis can have consequences for pregnancy and the developing child. Front Neurol. 2020, 11:554. 10.3389\/fneur.2020.00554","journal-title":"Front Neurol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-015-7963-5","article-title":"Myasthenia gravis: a clinical-immunological update","volume":"263","author":"Binks S","year":"2016","unstructured":"Binks S, Vincent A, Palace J. Myasthenia gravis: a clinical-immunological update. J Neurol. 2016, 263:826-34. 10.1007\/s00415-015-7963-5","journal-title":"J Neurol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2021.1973418","article-title":"Myasthenia gravis and covid-19 in pregnancy: a review of the literature and case series report","volume":"35","author":"Neykova KK","year":"2022","unstructured":"Neykova KK, Milanova M, Ignatov PN. Myasthenia gravis and covid-19 in pregnancy: a review of the literature and case series report. J Matern Fetal Neonatal Med. 2022, 35:8308-16. 10.1080\/14767058.2021.1973418","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1177\/1753495X211041899","article-title":"Myasthenia gravis in pregnancy: systematic review and case series","volume":"15","author":"Banner H","year":"2022","unstructured":"Banner H, Niles KM, Ryu M, Sermer M, Bril V, Murphy KE. Myasthenia gravis in pregnancy: systematic review and case series. Obstet Med. 2022, 15:108-17. 10.1177\/1753495X211041899","journal-title":"Obstet Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2020.09.015","article-title":"Myasthenia gravis and pregnancy","volume":"177","author":"Roche P","year":"2021","unstructured":"Roche P, Bouhour F. Myasthenia gravis and pregnancy. Rev Neurol (Paris). 2021, 177:215-9. 10.1016\/j.neurol.2020.09.015","journal-title":"Rev Neurol (Paris)"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57111277","article-title":"Fetal surveillance in pregnancies with myasthenia gravis","volume":"57","author":"Cimpoca-Raptis BA","year":"2021","unstructured":"Cimpoca-Raptis BA, Ciobanu AM, Gica N, Peltecu G, Mitrea D, Panaitescu AM. Fetal surveillance in pregnancies with myasthenia gravis. Medicina (Kaunas). 2021, 57:1277. 10.3390\/medicina57111277","journal-title":"Medicina (Kaunas)"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0b013e31828e92c0","article-title":"Myasthenia gravis and pregnancy","volume":"56","author":"Varner M","year":"2013","unstructured":"Varner M. Myasthenia gravis and pregnancy. Clin Obstet Gynecol. 2013, 56:372-81. 10.1097\/GRF.0b013e31828e92c0","journal-title":"Clin Obstet Gynecol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.09.003","article-title":"Management of myasthenia gravis in pregnancy","volume":"37","author":"Waters J","year":"2019","unstructured":"Waters J. Management of myasthenia gravis in pregnancy. Neurol Clin. 2019, 37:113-20. 10.1016\/j.ncl.2018.09.003","journal-title":"Neurol Clin"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.4103\/ijp.IJP_452_17","article-title":"Management of myasthenia gravis during pregnancy","volume":"50","author":"Bansal R","year":"2018","unstructured":"Bansal R, Goyal MK, Modi M. Management of myasthenia gravis during pregnancy. Indian J Pharmacol. 2018, 50:302-8. 10.4103\/ijp.IJP_452_17","journal-title":"Indian J Pharmacol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27064","article-title":"Myasthenia gravis and pregnancy","volume":"62","author":"Grover KM","year":"2020","unstructured":"Grover KM, Sripathi N. Myasthenia gravis and pregnancy. Muscle Nerve. 2020, 62:664-72. 10.1002\/mus.27064","journal-title":"Muscle Nerve"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.33588\/rn.7505.2022207","article-title":"Myasthenia gravis and pregnancy: impact and approach (Article in Spanish)","volume":"75","author":"Alfaro-Paredes K","year":"2022","unstructured":"Alfaro-Paredes K, Aguilar-Ydi\u00e1quez C, Aguirre-Flores R, Schulz-C\u00e1ceres H. Myasthenia gravis and pregnancy: impact and approach (Article in Spanish). Rev Neurol. 2022, 75:117-22. 10.33588\/rn.7505.2022207","journal-title":"Rev Neurol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/1751-486X.12206","article-title":"Myasthenia gravis in pregnancy","volume":"19","author":"Roth CK","year":"2015","unstructured":"Roth CK, Dent S, McDevitt K. Myasthenia gravis in pregnancy. Nurs Womens Health. 2015, 19:248-52. 10.1111\/1751-486X.12206","journal-title":"Nurs Womens Health"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-829590","article-title":"The management of myasthenia gravis in pregnancy","volume":"24","author":"Ciafaloni E","year":"2004","unstructured":"Ciafaloni E, Massey JM. The management of myasthenia gravis in pregnancy. Semin Neurol. 2004, 24:95-100. 10.1055\/s-2004-829590","journal-title":"Semin Neurol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1159\/000511957","article-title":"Eculizumab during pregnancy in a patient with treatment-refractory myasthenia gravis: a case report","volume":"13","author":"Vu T","year":"2021","unstructured":"Vu T, Harvey B, Suresh N, Farias J, Gooch C. Eculizumab during pregnancy in a patient with treatment-refractory myasthenia gravis: a case report. Case Rep Neurol. 2021, 13:65-72. 10.1159\/000511957","journal-title":"Case Rep Neurol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1212\/01.CON.0000443840.33310.bd","article-title":"Pregnancy and myasthenia gravis","volume":"20","author":"Massey JM","year":"2014","unstructured":"Massey JM, De Jesus-Acosta C. Pregnancy and myasthenia gravis. Continuum (Minneap Minn). 2014, 20:115-27. 10.1212\/01.CON.0000443840.33310.bd","journal-title":"Continuum (Minneap Minn)"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/cen3.12305","article-title":"Management of myasthenia gravis in pregnancy","volume":"7","author":"Shimizu Y","year":"2016","unstructured":"Shimizu Y, Kitagawa K. Management of myasthenia gravis in pregnancy. Clin Exp Neuroimmunol. 2016, 7:199-204. 10.1111\/cen3.12305","journal-title":"Clin Exp Neuroimmunol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.01.005","article-title":"An update: myasthenia gravis and pregnancy","volume":"36","author":"Hamel J","year":"2018","unstructured":"Hamel J, Ciafaloni E. An update: myasthenia gravis and pregnancy. Neurol Clin. 2018, 36:355-65. 10.1016\/j.ncl.2018.01.005","journal-title":"Neurol Clin"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.37897\/RJN.2021.2.19","article-title":"Myasthenia gravis in pregnancy: a rare association with an unpredictable evolution - three cases presentation","volume":"20","author":"Benjilany A","year":"2021","unstructured":"Benjilany A, Jaouad K. Myasthenia gravis in pregnancy: a rare association with an unpredictable evolution - three cases presentation. Rom J Neurol. 2021, 20:241-5. 10.37897\/RJN.2021.2.19","journal-title":"Rom J Neurol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-305572","article-title":"Myasthenia in pregnancy: best practice guidelines from a U.K. multispecialty working group","volume":"85","author":"Norwood F","year":"2014","unstructured":"Norwood F, Dhanjal M, Hill M, et al.. Myasthenia in pregnancy: best practice guidelines from a U.K. multispecialty working group. J Neurol Neurosurg Psychiatry. 2014, 85:538-43. 10.1136\/jnnp-2013-305572","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref65","article-title":"Myasthenia gravis in mothers and their newborns","volume":"34","author":"Plauch\u00e9 WC","year":"1991","unstructured":"Plauch\u00e9 WC. Myasthenia gravis in mothers and their newborns. Clin Obstet Gynecol. 1991, 34:82-99.","journal-title":"Clin Obstet Gynecol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.annfar.2004.01.014","article-title":"Myasthenia gravis, pregnancy and delivery: a series of ten cases (Article in French)","volume":"23","author":"Chabert L","year":"2004","unstructured":"Chabert L, Benhamou D. Myasthenia gravis, pregnancy and delivery: a series of ten cases (Article in French). Ann Fr Anesth Reanim. 2004, 23:459-64. 10.1016\/j.annfar.2004.01.014","journal-title":"Ann Fr Anesth Reanim"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/s1701-2163(16)30711-3","article-title":"Prevalence, management, and outcomes of preterm prelabour rupture of the membranes of women in Canada","volume":"27","author":"Smith G","year":"2005","unstructured":"Smith G, Rafuse C, Anand N, et al.. Prevalence, management, and outcomes of preterm prelabour rupture of the membranes of women in Canada. J Obstet Gynaecol Can. 2005, 27:547-53. 10.1016\/s1701-2163(16)30711-3","journal-title":"J Obstet Gynaecol Can"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/736024","article-title":"Myasthenia gravis in pregnancy: a case report","volume":"2012","author":"Berlit S","year":"2012","unstructured":"Berlit S, Tuschy B, Spaich S, S\u00fctterlin M, Schaffelder R. Myasthenia gravis in pregnancy: a case report. Case Rep Obstet Gynecol. 2012, 2012:736024. 10.1155\/2012\/736024","journal-title":"Case Rep Obstet Gynecol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.8.6.979","article-title":"Myasthenia gravis during pregnancy","volume":"8","author":"Ferrero S","year":"2008","unstructured":"Ferrero S, Esposito F, Biamonti M, Bentivoglio G, Ragni N. Myasthenia gravis during pregnancy. Expert Rev Neurother. 2008, 8:979-88. 10.1586\/14737175.8.6.979","journal-title":"Expert Rev Neurother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/163496-choices-and-challenges-with-treatment-of-myasthenia-gravis-in-pregnancy-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:03:50Z","timestamp":1707509030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/163496-choices-and-challenges-with-treatment-of-myasthenia-gravis-in-pregnancy-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":69,"URL":"https:\/\/doi.org\/10.7759\/cureus.42772","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,31]]}}}